What does PHARMACIE DES CLOITRES do?

PHARMACIE DES CLOITRES is a pharmacy in Amay. Private Limited, started on 23 January 1949, 1 establishment.

What is the address of PHARMACIE DES CLOITRES?

The registered office of PHARMACIE DES CLOITRES is located at Place Joseph Ramoux (AMA) 1, 4540 Amay.

Is PHARMACIE DES CLOITRES still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DES CLOITRES is active, legal situation “Normale toestand”, started on 23 January 1949.

Is PHARMACIE DES CLOITRES registered on Peppol?

Yes, PHARMACIE DES CLOITRES is registered on the Peppol network with ID 0208:0405621039.

What is the enterprise number of PHARMACIE DES CLOITRES?

The enterprise number of PHARMACIE DES CLOITRES is BE0405621039.

When was PHARMACIE DES CLOITRES founded?

PHARMACIE DES CLOITRES was founded on 23 January 1949.

Who are the directors of PHARMACIE DES CLOITRES?

According to the 2025 annual accounts, the directors of PHARMACIE DES CLOITRES are: LUCOMA SRL.

Is PHARMACIE DES CLOITRES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 January 1949; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DES CLOITRES make in 2025?

PHARMACIE DES CLOITRES posted a profit after taxes of € 54,916 in financial year 2025.

What is the revenue of PHARMACIE DES CLOITRES?

As a small company, PHARMACIE DES CLOITRES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 210,434.

How much does an employee at PHARMACIE DES CLOITRES earn?

The average wage cost per full-time employee at PHARMACIE DES CLOITRES was € 67,100 in 2025: staff costs of € 134,178 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DES CLOITRES have?

According to the 2025 annual accounts, PHARMACIE DES CLOITRES has 2 full-time equivalents (FTE).

PHARMACIE DES CLOITRES (Private Limited) - Amay

Dossier PHARMACIE DES CLOITRES, printed on 30 October 2026 from databakkes.be/en/0405621039/pharmacie-des-cloitres. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DES CLOITRES from Amay, company number BE0405621039, closed financial year 2025 with a result of € 54,916 after tax. For that financial year PHARMACIE DES CLOITRES recorded a gross margin of € 210,434 and equity of € 139,008. Compared with financial year 2024, the result moved from € 40,438 to € 54,916. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Growing

€ 139,008

▲ 40% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 54,916

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 61,269

▲ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 15,000 paid out

27 % of the profit went to the shareholders, mostly to LUCOMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 134,178

▼ 3% vs 2024

€ 67,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 107,899

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 30,715

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 191,757 Gross margin 2022: € 191,757 First fiscal year in the series	€ 174,282 Gross margin 2023: € 174,282 ▼ 9% vs 2022 (€ 191,757) Unfavourable step	€ 201,286 Gross margin 2024: € 201,286 ▲ 15% vs 2023 (€ 174,282) Favourable step	€ 210,434 Gross margin 2025: € 210,434 ▲ 5% vs 2024 (€ 201,286) Favourable step	▲ 5%
Profit after taxes	€ 39,297 Profit after taxes 2022: € 39,297 First fiscal year in the series	€ 21,894 Profit after taxes 2023: € 21,894 ▼ 44% vs 2022 (€ 39,297) Unfavourable step	€ 40,438 Profit after taxes 2024: € 40,438 ▲ 85% vs 2023 (€ 21,894) Favourable step	€ 54,916 Profit after taxes 2025: € 54,916 ▲ 36% vs 2024 (€ 40,438) Favourable step	▲ 36%
Equity	€ 66,760 Equity 2022: € 66,760 First fiscal year in the series	€ 58,654 Equity 2023: € 58,654 ▼ 12% vs 2022 (€ 66,760) Unfavourable step	€ 99,092 Equity 2024: € 99,092 ▲ 69% vs 2023 (€ 58,654) Favourable step	€ 139,008 Equity 2025: € 139,008 ▲ 40% vs 2024 (€ 99,092) Favourable step	▲ 40%
Total debts	€ 202,758 Total debts 2022: € 202,758 First fiscal year in the series	€ 233,328 Total debts 2023: € 233,328 ▲ 15% vs 2022 (€ 202,758) Unfavourable step	€ 208,524 Total debts 2024: € 208,524 ▼ 11% vs 2023 (€ 233,328) Favourable step	€ 242,589 Total debts 2025: € 242,589 ▲ 16% vs 2024 (€ 208,524) Unfavourable step	▲ 16%
Cash	€ 28,026 Cash 2022: € 28,026 First fiscal year in the series	€ 31,131 Cash 2023: € 31,131 ▲ 11% vs 2022 (€ 28,026) Favourable step	€ 46,780 Cash 2024: € 46,780 ▲ 50% vs 2023 (€ 31,131) Favourable step	€ 61,269 Cash 2025: € 61,269 ▲ 31% vs 2024 (€ 46,780) Favourable step	▲ 31%
Land & buildings	€ 10,444 Land & buildings 2022: € 10,444 First fiscal year in the series	€ 10,416 Land & buildings 2023: € 10,416 Unchanged (€ 10,444) Unchanged	€ 10,416 Land & buildings 2024: € 10,416 Unchanged (€ 10,416) Unchanged	€ 10,416 Land & buildings 2025: € 10,416 Unchanged (€ 10,416) Unchanged
Retained profit	€ 47,827 Retained profit 2022: € 47,827 First fiscal year in the series	€ 39,720 Retained profit 2023: € 39,720 ▼ 17% vs 2022 (€ 47,827) Unfavourable step	€ 80,158 Retained profit 2024: € 80,158 ▲ 102% vs 2023 (€ 39,720) Favourable step	€ 120,075 Retained profit 2025: € 120,075 ▲ 50% vs 2024 (€ 80,158) Favourable step	▲ 50%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 30,000) Unchanged	€ 15,000 Dividend 2025: € 15,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 269,518 Balance sheet total 2022: € 269,518 First fiscal year in the series	€ 291,982 Balance sheet total 2023: € 291,982 ▲ 8% vs 2022 (€ 269,518) Unchanged	€ 307,616 Balance sheet total 2024: € 307,616 ▲ 5% vs 2023 (€ 291,982) Unchanged	€ 381,597 Balance sheet total 2025: € 381,597 ▲ 24% vs 2024 (€ 307,616) Unchanged	▲ 24%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	2 Employees (FTE) 2023: 2 ▼ 0.1 vs 2022 (2.1) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of PHARMACIE DES CLOITRES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DES CLOITRES?

What happened at PHARMACIE DES CLOITRES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2026 New annual accounts for financial year 2025: profit of € 54,916 (▲ 36% vs 2024). filed late Source: NBB ↗
2010 LUCOMA SRL became a director. NBB
Jan 23, 1949 Start of the company according to the CBE. KBO
Oct 1, 1920 New establishment in Amay. KBO

In short

From € 39,297 profit in 2022 to € 54,916 profit in 2025.

Paid € 51,567 in corporate taxes since 2022.

Best year ever: 2025, with € 54,916 profit.

On average € 105,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

LUCOMA 100%

The stake of LUCOMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DES CLOITRES

Behind PHARMACIE DES CLOITRES is LUCOMA SRL. The shares are held by LUCOMA (100%).

Directors

According to the 2025 annual accounts

LUCOMA SRL

Associate · represented by Martine SWEGERYNEN

Also active at: SONEMA

since 2010

Shareholders

LUCOMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place Joseph Ramoux (AMA) 1

4540 Amay

2.010.824.450

Place Adolphe Grégoire(AMA) 2

4540 Amay

Active since 1 October 1920

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0405.621.039

VAT number

BE 0405.621.039

Registered office

Place Joseph Ramoux (AMA) 1, 4540 Amay

Names & denominations

PHARMACIE DES CLOITRES

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 January 1949

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DES CLOITRES

Financials

What happened to PHARMACIE DES CLOITRES?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions